Ani Pharmaceuticals reported $150.41M in Trade Debtors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Aerie Pharmaceuticals AERI:US $ 68.08M 4.46M
Ani Pharmaceuticals ANIP:US $ 150.41M 16.8M
Aurora Cannabis Inc ACB:CN 38.47M 11.64M
Canopy Growth Corp WEED:CN C$ 96.63M 183K
Depomed DEPO:US $ 49.23M 0.31M
Eli Lilly And LLY:US $ 7672.4M 133.3M
Emergent Biosolutions EBS:US $ 175M 6.8M
Endo International Ordinary Shares ENDP:US $ 498.9M 13.24M
Heron Therapeutics HRTX:US $ 40.3M 0.8M
Hikma Pharmaceutical HIK:LN 893M 82M
Knight Therapeutics Inc GUD:CN C$ 92.02M 10.67M
Lannett LCI:US $ 101.21M 0.91M
Nektar Therapeutics NKTR:US $ 10.01M 20.21M
Novartis NVS:US $ 8910M 232M
Perrigo Ordinary Shares PRGO:US $ 777.1M 65.3M
Teva Pharmaceutical TEVA:IT 4.47B 218M
Teva Pharmaceutical Industries TEVA:US $ 4471M 218M